Clinical Evaluation of a Novel Trifocal IOL

Sponsor
Alcon Research
Study ID
NCT07587138
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Aphakia
  • Cataract

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • LPYWT0 — DEVICE
    Investigational blue light filtering trifocal IOL implanted in the capsular bag of the eye during cataract surgery intended to remain in the eye for the lifetime of the subject.
  • PXYWT0 — DEVICE
    Commercially available blue light filtering trifocal IOL implanted in the capsular bag of the eye during cataract surgery intended to remain in the eye for the lifetime of the subject.
  • Cataract Surgery — PROCEDURE
    Removal of the cataractous lens by phacoemulsification followed by implantation of the IOL

Study Details

The purpose of this study is to understand the visual outcomes of the investigational intraocular lens (IOL) Model LPYWT0 when compared to the commercially marketed Clareon PanOptix Pro IOL Model PXYWT0.

Key Dates

First listed
May 14, 2026
Start date
Oct 31, 2026
Status verified
May 2026
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027

Study Design

Enrollment
66 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Other: LPYWT0 / PXYWT0
    Investigational IOL Model LPYWT0 implanted in the first operative eye during cataract surgery with Clareon PanOptix Pro IOL Model PXYWT0 in the second eye, as randomized. The second eye will be implanted 7-14 days after the first.
  • Other: PXYWT0 / LPYWT0
    Clareon PanOptix Pro IOL Model PXYWT0 implanted in the first operative eye during cataract surgery with investigational IOL Model LPYWT0 implanted in the second eye, as randomized. The second eye will be implanted 7-14 days after the first.

Primary Outcome Measure

Mean Monocular Photopic Best Corrected Distance Visual Acuity (BCDVA) [ Time Frame: Month 6 postoperative ]

Central Contacts

Related Studies